Replies to post #330 on Leap Therapeutics Inc (LPTX)

[The GidDy uP Kid]

aDDing... 🤓 

[tw0122]

.60 Oct 19th news date.. The final results will be presented in a Mini Oral Session at the European Society for Medical Oncology (ESMO) Congress 2025, taking place October 17-21 in Berlin, Germany.Mini Oral Session Details:Title: DeFianCe Trial: A randomized phase 2 trial of sirexatamab (DKN-01) plus bevacizumab and chemotherapy versus bevacizumab and chemotherapy as second-line therapy in advanced microsatellite stable (MSS) colorectal cancer (CRC)
Presenter: Zev A. Wainberg, M.D., Professor of Medicine and Co-Director of the GI Oncology Program at UCLA
Session Type: Mini Oral Session  
Session Category: GI Tumours, Lower Digestive
Date and Time: Sunday, October 19, 2025, 4:05 p.m. CEST..

[tw0122]

.6050 Someone loading up today heavy at .60 net accumulation 1.8m shares ...ready to fly anytime market makers let the goose loose one more time..$2 target